• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非侵入性尿液代谢组学方法筛查早期胃癌

Screening for Early Gastric Cancer Using a Noninvasive Urine Metabolomics Approach.

作者信息

Kwon Hyuk Nam, Lee Hyuk, Park Ji Won, Kim Young-Ho, Park Sunghyouk, Kim Jae J

机构信息

College of Pharmacy, Natural Product Research Institute, Seoul National University, Seoul 08826, Korea.

Stem Cells and Metabolism Research Program, Faculty of Medicine/Helsinki Institute of Life Science, University of Helsinki, FIN-00014 Helsinki, Finland.

出版信息

Cancers (Basel). 2020 Oct 9;12(10):2904. doi: 10.3390/cancers12102904.

DOI:10.3390/cancers12102904
PMID:33050308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7599479/
Abstract

The early detection of gastric cancer (GC) could decrease its incidence and mortality. However, there are currently no accurate noninvasive markers for GC screening. Therefore, we developed a noninvasive diagnostic approach, employing urine nuclear magnetic resonance (NMR) metabolomics, to discover putative metabolic markers associated with GC. Changes in urine metabolite levels during oncogenesis were evaluated using samples from 103 patients with GC and 100 age- and sex-matched healthy controls. Approximately 70% of the patients with GC ( = 69) had stage I GC, with the majority ( = 56) having intramucosal cancer. A multivariate statistical analysis of the urine NMR data well discriminated between the patient and control groups and revealed nine metabolites, including alanine, citrate, creatine, creatinine, glycerol, hippurate, phenylalanine, taurine, and 3-hydroxybutyrate, that contributed to the difference. A diagnostic performance test with a separate validation set exhibited a sensitivity and specificity of more than 90%, even with the intramucosal cancer samples only. In conclusion, the NMR-based urine metabolomics approach may have potential as a convenient screening method for the early detection of GC and may facilitate consequent endoscopic examination through risk stratification.

摘要

胃癌(GC)的早期检测可降低其发病率和死亡率。然而,目前尚无用于胃癌筛查的准确无创标志物。因此,我们开发了一种无创诊断方法,采用尿液核磁共振(NMR)代谢组学来发现与胃癌相关的潜在代谢标志物。使用来自103例胃癌患者和100例年龄及性别匹配的健康对照的样本,评估肿瘤发生过程中尿液代谢物水平的变化。约70%的胃癌患者(n = 69)为I期胃癌,其中大多数(n = 56)为黏膜内癌。对尿液NMR数据进行多变量统计分析,能够很好地区分患者组和对照组,并揭示了9种代谢物,包括丙氨酸、柠檬酸盐、肌酸、肌酐、甘油、马尿酸盐、苯丙氨酸、牛磺酸和3-羟基丁酸盐,这些代谢物导致了差异。即使仅使用黏膜内癌样本,在一个单独的验证集上进行的诊断性能测试也显示出超过90%的灵敏度和特异性。总之,基于NMR的尿液代谢组学方法可能有潜力作为一种方便的筛查方法用于胃癌的早期检测,并可能通过风险分层促进后续的内镜检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac9/7599479/7b04eff54216/cancers-12-02904-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac9/7599479/3a2fc97af439/cancers-12-02904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac9/7599479/4872111cb6ea/cancers-12-02904-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac9/7599479/7b04eff54216/cancers-12-02904-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac9/7599479/3a2fc97af439/cancers-12-02904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac9/7599479/4872111cb6ea/cancers-12-02904-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac9/7599479/7b04eff54216/cancers-12-02904-g003.jpg

相似文献

1
Screening for Early Gastric Cancer Using a Noninvasive Urine Metabolomics Approach.使用非侵入性尿液代谢组学方法筛查早期胃癌
Cancers (Basel). 2020 Oct 9;12(10):2904. doi: 10.3390/cancers12102904.
2
Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.基于核磁共振的代谢组学分析对胃癌进行无创诊断及根治性手术评估
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S736-42. doi: 10.1245/s10434-014-3886-0. Epub 2014 Aug 5.
3
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
4
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach.足月孕妇的尿液代谢组学:气相色谱/质谱联用和核磁共振方法。
J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:4-12. doi: 10.3109/14767058.2014.956403.
5
Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.评估代谢物谱作为噻唑烷二酮类药物对2型糖尿病患者和健康志愿者药理作用生物标志物的研究。
Br J Clin Pharmacol. 2007 May;63(5):562-74. doi: 10.1111/j.1365-2125.2006.02816.x.
6
Nuclear magnetic resonance metabolomic profiling of urine provides a noninvasive alternative to the identification of biomarkers associated with endometriosis.尿液的核磁共振代谢组学分析为识别与子宫内膜异位症相关的生物标志物提供了一种非侵入性的替代方法。
Fertil Steril. 2015 Nov;104(5):1202-9. doi: 10.1016/j.fertnstert.2015.07.1149. Epub 2015 Aug 18.
7
(1)H-NMR urinary metabolomic profiling for diagnosis of gastric cancer.用于胃癌诊断的氢核磁共振尿液代谢组学分析
Br J Cancer. 2016 Jan 12;114(1):59-62. doi: 10.1038/bjc.2015.414. Epub 2015 Dec 8.
8
Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.将代谢组学作为一种补充的组学方法用于实施胃癌患者一级亲属的风险标准。
Int J Mol Sci. 2018 Mar 7;19(3):750. doi: 10.3390/ijms19030750.
9
Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.生物流体中肺癌的代谢特征:尿液的基于 NMR 的代谢组学。
J Proteome Res. 2011 Jan 7;10(1):221-30. doi: 10.1021/pr100899x. Epub 2010 Nov 23.
10
NMR-based metabolomics study of canine bladder cancer.基于核磁共振的犬膀胱癌代谢组学研究。
Biochim Biophys Acta. 2012 Nov;1822(11):1807-14. doi: 10.1016/j.bbadis.2012.08.001. Epub 2012 Aug 8.

引用本文的文献

1
RBC balanced immuno-inflammatory signatures identify advanced breast cancer patients on CDK4/6 inhibitors at increased risk of progression and death.红细胞平衡免疫炎症特征可识别出接受CDK4/6抑制剂治疗的晚期乳腺癌患者,这些患者进展和死亡风险增加。
iScience. 2025 May 9;28(6):112620. doi: 10.1016/j.isci.2025.112620. eCollection 2025 Jun 20.
2
Metabolic Reprogramming of Gastric Cancer Revealed by a Liquid Chromatography-Mass Spectrometry-Based Metabolomics Study.基于液相色谱-质谱联用代谢组学研究揭示的胃癌代谢重编程
Metabolites. 2025 Mar 25;15(4):222. doi: 10.3390/metabo15040222.
3
Serum metabolic profiling analysis of chronic gastritis and gastric cancer by untargeted metabolomics.

本文引用的文献

1
Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.尿液-NMR 代谢组学用于筛查晚期结直肠腺瘤和早期结直肠癌。
Sci Rep. 2019 Mar 18;9(1):4786. doi: 10.1038/s41598-019-41216-y.
2
iTRAQ-Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer.iTRAQ 定量蛋白质组学方法鉴定了新型诊断生物标志物,这些标志物对胃癌的谷氨酰胺代谢和氧化还原平衡至关重要。
Proteomics Clin Appl. 2019 Jul;13(4):e1800038. doi: 10.1002/prca.201800038. Epub 2019 Jan 4.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
基于非靶向代谢组学的慢性胃炎和胃癌血清代谢谱分析
Ann Med Surg (Lond). 2024 Dec 19;87(2):583-597. doi: 10.1097/MS9.0000000000002977. eCollection 2025 Feb.
4
Plant Metabolomics: The Future of Anticancer Drug Discovery.植物代谢组学:抗癌药物发现的未来
Pharmaceuticals (Basel). 2024 Sep 30;17(10):1307. doi: 10.3390/ph17101307.
5
Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma.整合基因-代谢物关联网络分析揭示胃腺癌中的关键代谢途径。
Heliyon. 2024 Aug 30;10(17):e37156. doi: 10.1016/j.heliyon.2024.e37156. eCollection 2024 Sep 15.
6
Metabolomic profiling of upper GI malignancies in blood and tissue: a systematic review and meta-analysis.上消化道恶性肿瘤的血液和组织代谢组学分析:系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2024 Jul 1;150(7):331. doi: 10.1007/s00432-024-05857-5.
7
Urinary metabolic profiles during eradication in chronic gastritis.慢性胃炎根除治疗期间的尿液代谢谱。
World J Clin Cases. 2024 Feb 16;12(5):951-965. doi: 10.12998/wjcc.v12.i5.951.
8
Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer.异常的精氨酸合成会使胃中三分之一段癌患者的预后更差。
Cancer Cell Int. 2024 Jan 3;24(1):6. doi: 10.1186/s12935-023-03200-5.
9
The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma.液相色谱-质谱联用非靶向代谢组学在滤泡性甲状腺癌诊断中的潜在价值。
Front Oncol. 2022 Dec 22;12:1076548. doi: 10.3389/fonc.2022.1076548. eCollection 2022.
10
Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study.代谢组学研究鉴定胆汁酸为胃癌的潜在生物标志物:一项病例对照研究。
Front Endocrinol (Lausanne). 2022 Nov 18;13:1039786. doi: 10.3389/fendo.2022.1039786. eCollection 2022.
全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Circulating miR-21 as novel biomarker in gastric cancer: Diagnostic and prognostic biomarker.循环miR-21作为胃癌的新型生物标志物:诊断和预后生物标志物。
J Cancer Res Ther. 2018 Jan-Mar;14(2):475. doi: 10.4103/0973-1482.175428.
5
Recommended strategies for spectral processing and post-processing of 1D H-NMR data of biofluids with a particular focus on urine.生物流体一维氢核磁共振数据的光谱处理和后处理推荐策略,特别关注尿液。
Metabolomics. 2018;14(3):31. doi: 10.1007/s11306-018-1321-4. Epub 2018 Feb 12.
6
Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study.早期胃癌内镜切除与手术治疗的长期结局:一项非劣效性匹配队列研究
Am J Gastroenterol. 2016 Feb;111(2):240-9. doi: 10.1038/ajg.2015.427. Epub 2016 Jan 19.
7
(1)H-NMR urinary metabolomic profiling for diagnosis of gastric cancer.用于胃癌诊断的氢核磁共振尿液代谢组学分析
Br J Cancer. 2016 Jan 12;114(1):59-62. doi: 10.1038/bjc.2015.414. Epub 2015 Dec 8.
8
Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.使用液相色谱/质谱联用技术对胃癌进行代谢组学分析
Appl Biochem Biotechnol. 2015 Aug;176(8):2170-84. doi: 10.1007/s12010-015-1706-z. Epub 2015 Jun 19.
9
Endocytoscopy is a promising modality with high diagnostic accuracy for gastric cancer.内镜超声检查是一种对胃癌具有高诊断准确性的有前景的检查方式。
Endoscopy. 2015 Jan;47(1):19-25. doi: 10.1055/s-0034-1377965. Epub 2014 Sep 15.
10
Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling.基于核磁共振的代谢组学分析对胃癌进行无创诊断及根治性手术评估
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S736-42. doi: 10.1245/s10434-014-3886-0. Epub 2014 Aug 5.